MARKET

OBLN

OBLN

Obalon
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.9698
-0.0001
-0.01%
Closed 16:30 06/01 EDT
OPEN
0.9600
PREV CLOSE
0.9699
HIGH
0.9800
LOW
0.9200
VOLUME
156.36K
TURNOVER
--
52 WEEK HIGH
15.80
52 WEEK LOW
0.6200
MARKET CAP
7.50M
P/E (TTM)
-0.1319
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 1 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average OBLN stock price target is 0.9000 with a high estimate of 0.9000 and a low estimate of 0.9000.

EPS

OBLN News

More
Obalon Therapeutics Inc Says Unable To Identify A Strategic Transaction That Board Of Directors Believes To Be In Best Interests Of Shareholders
SAN DIEGO, May 11, 2020 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (“Obalon” or the “Company”) (NASDAQ:OBLN), a vertically integrated weight loss solutions company commercializing the first and
Benzinga · 05/11 12:32
William Plovanic Resigns as President and Chief Executive Officer and Will Continue to Serve Solely as Director
GlobeNewswire · 05/08 13:00
William Plovanic Resigns As President And Chief Executive Officer And Will Continue To Serve Solely As Director
Benzinga · 05/08 12:21
Obalon Gas-Filled Balloon Not Subject of Fourth FDA Letter to Health Care Providers Related To Serious Risks, Including Death, With Liquid-Filled Intragastric Balloons
GlobeNewswire · 04/28 14:00
UPDATE: Obalon Reported No Device-Related Serious Adverse Events For First 141 Patients Completing Therapy
Benzinga · 04/28 13:04
CHK, APDN, VET and NNDM among midday movers
Seeking Alpha - Article · 04/15 16:41
MT, SSL among premarket losers
Seeking Alpha - Article · 04/15 13:16
Obalon Therapeutics Shares Spike To Session High On Uptick In Volume, Now Up 22%; Hearing Co. Granted Patent For '545 Related To 'Intragastric device system'
https://twitter.com/Patent_Grants/status/1250133650458529796
Benzinga · 04/14 18:50

Industry

Medical Equipment, Supplies & Distribution
-0.27%
Healthcare Equipment & Supplies
+0.10%

Hot Stocks

Symbol
Price
%Change

About OBLN

Obalon Therapeutics, Inc. is a commercial-stage medical device company focused on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. The Company's product, Obalon balloon system, is a swallowable, gas-filled intragastric balloon designed to provide weight loss in obese patients. The Obalon balloon system is intended to be used as an adjunct to a moderate intensity diet and behavior modification program. All balloons must be removed six months after the first balloon is placed. The Obalon balloon system intends to provide patients and physicians with a reversible and repeatable weight loss solution in an outpatient setting, without altering patient anatomy or requiring surgery. The Company has received Premarket approval (PMA) for its Obalon balloon system based on the results of its United States pivotal clinical trial, referred to as the SMART trial.
More

Webull offers kinds of Obalon Therapeutics Inc stock information, including NASDAQ:OBLN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OBLN stock news, and many more online research tools to help you make informed decisions.